JP2007524360A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007524360A5 JP2007524360A5 JP2006503442A JP2006503442A JP2007524360A5 JP 2007524360 A5 JP2007524360 A5 JP 2007524360A5 JP 2006503442 A JP2006503442 A JP 2006503442A JP 2006503442 A JP2006503442 A JP 2006503442A JP 2007524360 A5 JP2007524360 A5 JP 2007524360A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- nell1
- nucleic acid
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 120
- 150000007523 nucleic acids Chemical class 0.000 claims description 109
- 238000000034 method Methods 0.000 claims description 89
- 101000979284 Homo sapiens Protein kinase C-binding protein NELL1 Proteins 0.000 claims description 86
- 210000004027 cell Anatomy 0.000 claims description 83
- 108020004707 nucleic acids Proteins 0.000 claims description 82
- 102000039446 nucleic acids Human genes 0.000 claims description 82
- 102100023068 Protein kinase C-binding protein NELL1 Human genes 0.000 claims description 79
- 101000995264 Homo sapiens Protein kinase C-binding protein NELL2 Proteins 0.000 claims description 48
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 47
- 102100034433 Protein kinase C-binding protein NELL2 Human genes 0.000 claims description 42
- 101150033362 NELL1 gene Proteins 0.000 claims description 28
- 241000238631 Hexapoda Species 0.000 claims description 25
- 230000014509 gene expression Effects 0.000 claims description 23
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims description 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 11
- 210000000963 osteoblast Anatomy 0.000 claims description 10
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 claims description 9
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 claims description 9
- 108010036176 Melitten Proteins 0.000 claims description 9
- 239000007943 implant Substances 0.000 claims description 9
- VDXZNPDIRNWWCW-JFTDCZMZSA-N melittin Chemical group NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(N)=O)C(N)=O)CC1=CNC2=CC=CC=C12 VDXZNPDIRNWWCW-JFTDCZMZSA-N 0.000 claims description 9
- 210000000988 bone and bone Anatomy 0.000 claims description 8
- 230000002308 calcification Effects 0.000 claims description 6
- 101150086605 Runx2 gene Proteins 0.000 claims description 5
- 101100221606 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) COS7 gene Proteins 0.000 claims description 5
- 230000001605 fetal effect Effects 0.000 claims description 4
- 102000002260 Alkaline Phosphatase Human genes 0.000 claims description 3
- 108020004774 Alkaline Phosphatase Proteins 0.000 claims description 3
- 102000004067 Osteocalcin Human genes 0.000 claims description 2
- 108090000573 Osteocalcin Proteins 0.000 claims description 2
- 210000000845 cartilage Anatomy 0.000 claims description 2
- 230000003248 secreting effect Effects 0.000 claims 29
- 230000011164 ossification Effects 0.000 claims 24
- 210000005009 osteogenic cell Anatomy 0.000 claims 22
- 239000000203 mixture Substances 0.000 claims 21
- 230000001939 inductive effect Effects 0.000 claims 16
- 239000011159 matrix material Substances 0.000 claims 16
- 239000003795 chemical substances by application Substances 0.000 claims 15
- 210000004962 mammalian cell Anatomy 0.000 claims 12
- 102000008186 Collagen Human genes 0.000 claims 11
- 108010035532 Collagen Proteins 0.000 claims 11
- 229920001436 collagen Polymers 0.000 claims 11
- 229920001184 polypeptide Polymers 0.000 claims 10
- 102100024506 Bone morphogenetic protein 2 Human genes 0.000 claims 8
- 102100022544 Bone morphogenetic protein 7 Human genes 0.000 claims 8
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims 8
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 8
- 101000762366 Homo sapiens Bone morphogenetic protein 2 Proteins 0.000 claims 8
- 101000899361 Homo sapiens Bone morphogenetic protein 7 Proteins 0.000 claims 8
- 210000001612 chondrocyte Anatomy 0.000 claims 8
- 239000000758 substrate Substances 0.000 claims 7
- 230000000694 effects Effects 0.000 claims 6
- 210000003041 ligament Anatomy 0.000 claims 6
- 210000000130 stem cell Anatomy 0.000 claims 6
- 210000002435 tendon Anatomy 0.000 claims 6
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims 4
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims 4
- 239000002771 cell marker Substances 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 4
- 230000004072 osteoblast differentiation Effects 0.000 claims 4
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims 4
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 claims 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 3
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 claims 3
- 206010020880 Hypertrophy Diseases 0.000 claims 3
- 229940072056 alginate Drugs 0.000 claims 3
- 235000010443 alginic acid Nutrition 0.000 claims 3
- 229920000615 alginic acid Polymers 0.000 claims 3
- 230000032631 intramembranous ossification Effects 0.000 claims 3
- 230000002188 osteogenic effect Effects 0.000 claims 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 claims 2
- 239000001856 Ethyl cellulose Substances 0.000 claims 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 claims 2
- 102000009123 Fibrin Human genes 0.000 claims 2
- 108010073385 Fibrin Proteins 0.000 claims 2
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 claims 2
- 108010010803 Gelatin Proteins 0.000 claims 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 claims 2
- 239000004354 Hydroxyethyl cellulose Substances 0.000 claims 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims 2
- 229920002125 Sokalan® Polymers 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 229910052586 apatite Inorganic materials 0.000 claims 2
- 210000002798 bone marrow cell Anatomy 0.000 claims 2
- 210000002805 bone matrix Anatomy 0.000 claims 2
- 230000010478 bone regeneration Effects 0.000 claims 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 claims 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 claims 2
- 230000001413 cellular effect Effects 0.000 claims 2
- 229960005188 collagen Drugs 0.000 claims 2
- 229960000633 dextran sulfate Drugs 0.000 claims 2
- 210000001951 dura mater Anatomy 0.000 claims 2
- 210000002308 embryonic cell Anatomy 0.000 claims 2
- 229920001249 ethyl cellulose Polymers 0.000 claims 2
- 235000019325 ethyl cellulose Nutrition 0.000 claims 2
- 229950003499 fibrin Drugs 0.000 claims 2
- 210000002950 fibroblast Anatomy 0.000 claims 2
- -1 fucan Chemical compound 0.000 claims 2
- 229920000159 gelatin Polymers 0.000 claims 2
- 239000008273 gelatin Substances 0.000 claims 2
- 229940014259 gelatin Drugs 0.000 claims 2
- 235000019322 gelatine Nutrition 0.000 claims 2
- 235000011852 gelatine desserts Nutrition 0.000 claims 2
- 230000035876 healing Effects 0.000 claims 2
- 229920000669 heparin Polymers 0.000 claims 2
- 229960002897 heparin Drugs 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 claims 2
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 claims 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 2
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 claims 2
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 claims 2
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 claims 2
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 claims 2
- 239000012528 membrane Substances 0.000 claims 2
- 108020004999 messenger RNA Proteins 0.000 claims 2
- 229920000609 methyl cellulose Polymers 0.000 claims 2
- 239000001923 methylcellulose Substances 0.000 claims 2
- 235000010981 methylcellulose Nutrition 0.000 claims 2
- VSIIXMUUUJUKCM-UHFFFAOYSA-D pentacalcium;fluoride;triphosphate Chemical compound [F-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O VSIIXMUUUJUKCM-UHFFFAOYSA-D 0.000 claims 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 claims 1
- 235000014653 Carica parviflora Nutrition 0.000 claims 1
- 229920001661 Chitosan Polymers 0.000 claims 1
- 229920001287 Chondroitin sulfate Polymers 0.000 claims 1
- 241000243321 Cnidaria Species 0.000 claims 1
- 102000004237 Decorin Human genes 0.000 claims 1
- 108090000738 Decorin Proteins 0.000 claims 1
- 239000004471 Glycine Substances 0.000 claims 1
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Polymers OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 claims 1
- 229920002971 Heparan sulfate Polymers 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims 1
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 claims 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims 1
- 229920001244 Poly(D,L-lactide) Polymers 0.000 claims 1
- 229920002732 Polyanhydride Polymers 0.000 claims 1
- 229920000954 Polyglycolide Polymers 0.000 claims 1
- 229920000331 Polyhydroxybutyrate Polymers 0.000 claims 1
- 229920001710 Polyorthoester Polymers 0.000 claims 1
- 229920001213 Polysorbate 20 Polymers 0.000 claims 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 claims 1
- 229960000583 acetic acid Drugs 0.000 claims 1
- 239000013543 active substance Substances 0.000 claims 1
- 229920013820 alkyl cellulose Polymers 0.000 claims 1
- 229940061720 alpha hydroxy acid Drugs 0.000 claims 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 claims 1
- 229940024606 amino acid Drugs 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 230000001640 apoptogenic effect Effects 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- 239000005313 bioactive glass Substances 0.000 claims 1
- 239000003462 bioceramic Substances 0.000 claims 1
- 230000033558 biomineral tissue development Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 239000001506 calcium phosphate Substances 0.000 claims 1
- 229910000389 calcium phosphate Inorganic materials 0.000 claims 1
- 235000011010 calcium phosphates Nutrition 0.000 claims 1
- ZOMBKNNSYQHRCA-UHFFFAOYSA-J calcium sulfate hemihydrate Chemical compound O.[Ca+2].[Ca+2].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O ZOMBKNNSYQHRCA-UHFFFAOYSA-J 0.000 claims 1
- 230000003185 calcium uptake Effects 0.000 claims 1
- 125000002091 cationic group Chemical group 0.000 claims 1
- 229940045110 chitosan Drugs 0.000 claims 1
- 229940059329 chondroitin sulfate Drugs 0.000 claims 1
- 230000004069 differentiation Effects 0.000 claims 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 230000002255 enzymatic effect Effects 0.000 claims 1
- 230000009969 flowable effect Effects 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 229930195712 glutamate Natural products 0.000 claims 1
- 150000004676 glycans Chemical class 0.000 claims 1
- 229960004198 guanidine Drugs 0.000 claims 1
- KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 claims 1
- 229940099552 hyaluronan Drugs 0.000 claims 1
- 229960003160 hyaluronic acid Drugs 0.000 claims 1
- 230000007062 hydrolysis Effects 0.000 claims 1
- 238000006460 hydrolysis reaction Methods 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000007246 mechanism Effects 0.000 claims 1
- 230000006576 neuronal survival Effects 0.000 claims 1
- 229920001993 poloxamer 188 Polymers 0.000 claims 1
- 229920001432 poly(L-lactide) Polymers 0.000 claims 1
- 229920001308 poly(aminoacid) Polymers 0.000 claims 1
- 229920005583 poly(anhydride-co-imide) Polymers 0.000 claims 1
- 239000005015 poly(hydroxybutyrate) Substances 0.000 claims 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 claims 1
- 229920002463 poly(p-dioxanone) polymer Polymers 0.000 claims 1
- 229920002627 poly(phosphazenes) Polymers 0.000 claims 1
- 239000004584 polyacrylic acid Substances 0.000 claims 1
- 229920000447 polyanionic polymer Polymers 0.000 claims 1
- 229920001230 polyarylate Polymers 0.000 claims 1
- 229920001610 polycaprolactone Polymers 0.000 claims 1
- 229920000515 polycarbonate Polymers 0.000 claims 1
- 239000004417 polycarbonate Substances 0.000 claims 1
- 229920000728 polyester Polymers 0.000 claims 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 claims 1
- 229920001223 polyethylene glycol Polymers 0.000 claims 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 claims 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 claims 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 1
- 229920001282 polysaccharide Polymers 0.000 claims 1
- 239000005017 polysaccharide Substances 0.000 claims 1
- 229920000136 polysorbate Polymers 0.000 claims 1
- 229950008882 polysorbate Drugs 0.000 claims 1
- 229940068977 polysorbate 20 Drugs 0.000 claims 1
- 229920000053 polysorbate 80 Polymers 0.000 claims 1
- 229940068968 polysorbate 80 Drugs 0.000 claims 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 claims 1
- 229920002451 polyvinyl alcohol Polymers 0.000 claims 1
- 239000003352 sequestering agent Substances 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
- 229960002668 sodium chloride Drugs 0.000 claims 1
- 239000005720 sucrose Substances 0.000 claims 1
- 229960004793 sucrose Drugs 0.000 claims 1
- 239000004094 surface-active agent Substances 0.000 claims 1
- 229920001059 synthetic polymer Polymers 0.000 claims 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims 1
- 108091028043 Nucleic acid sequence Proteins 0.000 description 27
- 239000002299 complementary DNA Substances 0.000 description 23
- 125000003275 alpha amino acid group Chemical group 0.000 description 16
- 101100133162 Rattus norvegicus Nell1 gene Proteins 0.000 description 7
- 102000053009 human NELL1 Human genes 0.000 description 7
- 241000287828 Gallus gallus Species 0.000 description 6
- 101100293963 Mus musculus Nell1 gene Proteins 0.000 description 6
- 101100133166 Mus musculus Nell2 gene Proteins 0.000 description 6
- 101100133168 Rattus norvegicus Nell2 gene Proteins 0.000 description 6
- 102000053017 human NELL2 Human genes 0.000 description 6
- 238000001262 western blot Methods 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000012679 serum free medium Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000010603 microCT Methods 0.000 description 2
- 210000002500 microbody Anatomy 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 2
- 238000010186 staining Methods 0.000 description 2
- 238000011830 transgenic mouse model Methods 0.000 description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- WQZGKKKJIJFFOK-FPRJBGLDSA-N beta-D-galactose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-FPRJBGLDSA-N 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 238000001000 micrograph Methods 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000004017 serum-free culture medium Substances 0.000 description 1
- 241000701161 unidentified adenovirus Species 0.000 description 1
Images
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44567203P | 2003-02-07 | 2003-02-07 | |
| PCT/US2003/029281 WO2004024893A2 (en) | 2002-09-13 | 2003-09-15 | Nell-1 enhanced bone mineralization |
| PCT/US2004/003808 WO2004072100A2 (en) | 2003-02-07 | 2004-02-09 | Nell peptide expression systems and bone formation activity of nell peptide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007524360A JP2007524360A (ja) | 2007-08-30 |
| JP2007524360A5 true JP2007524360A5 (https=) | 2009-09-03 |
Family
ID=32869406
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006503442A Pending JP2007524360A (ja) | 2003-02-07 | 2004-02-09 | Ｎｅｌｌペプチドの発現系及びｎｅｌｌペプチドの骨形成活性 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7544486B2 (https=) |
| EP (1) | EP1594889B1 (https=) |
| JP (1) | JP2007524360A (https=) |
| CN (1) | CN101018562A (https=) |
| AT (1) | ATE504649T1 (https=) |
| CA (1) | CA2515208A1 (https=) |
| DE (1) | DE602004032107D1 (https=) |
| ES (1) | ES2366950T3 (https=) |
| WO (1) | WO2004072100A2 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3646191B2 (ja) * | 1996-03-19 | 2005-05-11 | 大塚製薬株式会社 | ヒト遺伝子 |
| US6005088A (en) | 1996-03-19 | 1999-12-21 | Otsuka Pharmaceutical Co., Ltd. | Human NPIK gene |
| US7884066B2 (en) | 1999-10-05 | 2011-02-08 | The Regents Of The University Of California | NELL-1 enhanced bone mineralization |
| US7687462B2 (en) * | 1999-10-05 | 2010-03-30 | The Regents Of The University Of California | Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition |
| DE602004032107D1 (de) * | 2003-02-07 | 2011-05-19 | Univ California | Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids |
| EP1694352A2 (en) * | 2003-11-19 | 2006-08-30 | DeveloGen Aktiengesellschaft | Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| US7691607B2 (en) | 2004-02-09 | 2010-04-06 | The Regents Of The University Of California | Expression system of NELL peptide |
| CN101115839B (zh) * | 2004-08-30 | 2011-05-04 | 杨梦甦 | 通过rh核心蛋白聚糖-Fc融合蛋白抑制纤维发生的方法 |
| US7833968B2 (en) | 2005-02-16 | 2010-11-16 | The Regents Of The University Of California | Pharmaceutical compositions for treating or preventing bone conditions |
| US8206735B2 (en) * | 2006-07-11 | 2012-06-26 | Foresee Pharmaceuticals, Llc | Pharmaceutical compositions for sustained release delivery of peptides |
| JP2008212265A (ja) * | 2007-03-01 | 2008-09-18 | Niigata Univ | 培養人工骨及びその作製方法 |
| EP2200630B1 (en) | 2007-09-28 | 2013-05-01 | Ut-Battelle, Llc | Nell1 for use in treating cardiovascular disorders |
| WO2009042859A1 (en) * | 2007-09-28 | 2009-04-02 | Ut-Battelle, Llc | Methods for promoting wound healing and muscle regeneration with the cell signaling protein nell 1 |
| EP2214697A4 (en) * | 2007-10-30 | 2011-05-18 | Univ California | NELL-1 COMPOSITIONS |
| JP2011016723A (ja) * | 2007-11-02 | 2011-01-27 | Katayama Kagaku Kogyo Kk | 骨及び軟骨形成タンパク質を含有する医薬品及び医療器具 |
| JP5641477B2 (ja) * | 2008-08-04 | 2014-12-17 | 学校法人昭和大学 | Ｎｅｌｌ−１による組織・臓器異所再生制御技術 |
| GB2463474B (en) * | 2008-09-11 | 2012-05-02 | Agency Science Tech & Res | Therapeutic bone growth and regeneration |
| CA2739608A1 (en) * | 2008-10-07 | 2010-04-15 | The Regents Of The University Of California | Recombinant nell protein production |
| US20110002893A1 (en) * | 2008-11-03 | 2011-01-06 | Ut-Battelle, Llc | Diagnosis and treatment of congenital heart defects using nell1 |
| US9447155B2 (en) | 2009-03-25 | 2016-09-20 | The Regents Of The University Of California | Isoform Nell-1 peptide |
| WO2011022071A2 (en) * | 2009-08-20 | 2011-02-24 | The Regents Of The University Of California | Cardiac compositions |
| EP2525808A2 (en) | 2010-01-19 | 2012-11-28 | The Trustees Of Columbia University In The City Of New York | Osteocalcin as a treatment for male reproductive disorders |
| WO2011091244A1 (en) * | 2010-01-21 | 2011-07-28 | NellOne Therapeutics, Inc. | Methods to treat or prevent a skin condition using a nell1 peptide |
| US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
| US8551525B2 (en) | 2010-12-23 | 2013-10-08 | Biostructures, Llc | Bone graft materials and methods |
| WO2014152497A2 (en) | 2013-03-15 | 2014-09-25 | The Trustees Of Columbia University In The City Of New York | Osteocalcin as a treatment for cognitive disorders |
| US20150037436A1 (en) | 2013-07-30 | 2015-02-05 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| US9616114B1 (en) | 2014-09-18 | 2017-04-11 | David Gordon Bermudes | Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity |
| JP7175608B2 (ja) | 2014-11-19 | 2022-11-21 | ザ トラスティーズ オブ コロンビア ユニバーシティ イン ザ シティ オブ ニューヨーク | 加齢に伴うフレイルのための治療としてのオステオカルシン |
| US10676723B2 (en) | 2015-05-11 | 2020-06-09 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US10912864B2 (en) | 2015-07-24 | 2021-02-09 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| US10973953B1 (en) | 2016-08-18 | 2021-04-13 | Musculoskeletal Transplant Foundation | Methods and compositions for preparing transplant tissue |
| US10752663B2 (en) | 2016-08-29 | 2020-08-25 | NellOne Therapeutics, Inc. | Methods and compositions for regenerating tissues |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| US11364323B2 (en) | 2018-09-17 | 2022-06-21 | Rejuvablast LLC | Combination grafts for tissue repair or regeneration applications |
| AU2019204031A1 (en) | 2019-05-31 | 2020-12-17 | Musculoskeletal Transplant Foundation | Acellular soft tissue-derived matrices and methods for preparing same |
| CN110420350B (zh) * | 2019-08-28 | 2021-10-22 | 深圳先进技术研究院 | 复合生物玻璃的粘附温敏水凝胶及其制备方法和应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4394370A (en) * | 1981-09-21 | 1983-07-19 | Jefferies Steven R | Bone graft material for osseous defects and method of making same |
| US4409332A (en) * | 1982-01-12 | 1983-10-11 | Jefferies Steven R | Collagen-enzyme conjugates that exhibit no inflammatory response and method for making the same |
| US5395502A (en) * | 1988-11-14 | 1995-03-07 | Anthony R. Torres | Apparatus for performing and universally detecting capillary isoelectric focusing without mobilization using concentration gradient imaging systems |
| US5486359A (en) * | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
| US5674844A (en) * | 1991-03-11 | 1997-10-07 | Creative Biomolecules, Inc. | Treatment to prevent loss of and/or increase bone mass in metabolic bone diseases |
| US5674725A (en) * | 1991-07-11 | 1997-10-07 | British Technology Group Limited | Implant materials having a phosphatase and an organophosphorus compound for in vivo mineralization of bone |
| US5385887A (en) * | 1993-09-10 | 1995-01-31 | Genetics Institute, Inc. | Formulations for delivery of osteogenic proteins |
| US5763416A (en) * | 1994-02-18 | 1998-06-09 | The Regent Of The University Of Michigan | Gene transfer into bone cells and tissues |
| US5942496A (en) * | 1994-02-18 | 1999-08-24 | The Regent Of The University Of Michigan | Methods and compositions for multiple gene transfer into bone cells |
| US6083690A (en) * | 1995-06-02 | 2000-07-04 | Osteoscreen, Inc. | Methods and compositions for identifying osteogenic agents |
| US6352972B1 (en) * | 1995-06-06 | 2002-03-05 | Marcel E. Nimni | Bone morphogenetic proteins and their use in bone growth |
| US6008208A (en) * | 1995-10-23 | 1999-12-28 | Osteoscreen, Inc. | Compositions and methods for treating bone deficit conditions |
| US6048964A (en) * | 1995-12-12 | 2000-04-11 | Stryker Corporation | Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| US6200606B1 (en) * | 1996-01-16 | 2001-03-13 | Depuy Orthopaedics, Inc. | Isolation of precursor cells from hematopoietic and nonhematopoietic tissues and their use in vivo bone and cartilage regeneration |
| JP3646191B2 (ja) * | 1996-03-19 | 2005-05-11 | 大塚製薬株式会社 | ヒト遺伝子 |
| US6005088A (en) * | 1996-03-19 | 1999-12-21 | Otsuka Pharmaceutical Co., Ltd. | Human NPIK gene |
| US6077987A (en) * | 1997-09-04 | 2000-06-20 | North Shore-Long Island Jewish Research Institute | Genetic engineering of cells to enhance healing and tissue regeneration |
| US6462019B1 (en) * | 1998-07-10 | 2002-10-08 | Osteoscreen, Inc. | Inhibitors of proteasomal activity and production for stimulating bone growth |
| DE69934694T2 (de) * | 1998-08-10 | 2007-10-04 | Agensys, Inc., Santa Monica | Bpc-1: ein ausgeschiedenes gehirnspezifisches protein das von prostata- und blasen-krebszellen exprimiert und ausgeschieden wird |
| US7052856B2 (en) | 1999-10-05 | 2006-05-30 | The Regents Of The University Of California | NELL-1 enhanced bone mineralization |
| WO2004024893A2 (en) | 2002-09-13 | 2004-03-25 | The Regents Of The University Of California | Nell-1 enhanced bone mineralization |
| US20030039968A1 (en) | 2001-07-10 | 2003-02-27 | Applera Corporation | Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof |
| DE602004032107D1 (de) * | 2003-02-07 | 2011-05-19 | Univ California | Nell-peptidexpressionssysteme und knochenbildende aktivität des nell-peptids |
| TWI296483B (en) * | 2005-12-07 | 2008-05-01 | Marketech Int Corp | Apparatus and method for adjusting input image based on characteristics of display system |
-
2004
- 2004-02-09 DE DE602004032107T patent/DE602004032107D1/de not_active Expired - Lifetime
- 2004-02-09 ES ES04709500T patent/ES2366950T3/es not_active Expired - Lifetime
- 2004-02-09 AT AT04709500T patent/ATE504649T1/de not_active IP Right Cessation
- 2004-02-09 US US10/544,553 patent/US7544486B2/en not_active Expired - Lifetime
- 2004-02-09 JP JP2006503442A patent/JP2007524360A/ja active Pending
- 2004-02-09 CA CA002515208A patent/CA2515208A1/en not_active Abandoned
- 2004-02-09 EP EP04709500A patent/EP1594889B1/en not_active Expired - Lifetime
- 2004-02-09 WO PCT/US2004/003808 patent/WO2004072100A2/en not_active Ceased
- 2004-02-09 CN CNA2004800094501A patent/CN101018562A/zh active Pending
-
2009
- 2009-03-09 US US12/400,714 patent/US7807787B2/en not_active Expired - Lifetime
- 2009-03-09 US US12/400,715 patent/US8048646B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007524360A5 (https=) | ||
| EP1594889B1 (en) | Nell peptide expression systems and bone formation activity of nell peptide | |
| US6398816B1 (en) | Genetic engineering of cells to enhance healing and tissue regeneration | |
| Lee | Cytokine delivery and tissue engineering | |
| Lieberman et al. | The role of growth factors in the repair of bone: biology and clinical applications | |
| Ripamonti et al. | Tissue morphogenesis and regeneration by bone morphogenetic proteins | |
| Fei et al. | Fibroblast growth factor-2, bone homeostasis and fracture repair | |
| CA2151547C (en) | Recombinant chimeric proteins and methods of use thereof | |
| JP2008530227A (ja) | 骨状態を治療または予防する薬剤組成物 | |
| JP2010520212A (ja) | 骨石灰化を増進するｎｅｌｌ−１ | |
| US20050288229A1 (en) | Connective Tissue Stimulating Peptides | |
| Jin et al. | Growth differentiation factor 5 regulation in bone regeneration | |
| CN115916239A (zh) | 用于靶向治疗性递送至骨的组合物和方法 | |
| US20070248641A1 (en) | Use of Del-1 in Hair, Bone and Cartilage Regeneration | |
| Huang et al. | Engineering a self-assembling leucine zipper hydrogel system with function-specific motifs for tissue regeneration | |
| KR20120018202A (ko) | 파이브로모듈린 펩타이드 | |
| AU2010271157A1 (en) | Enhancement of BMP retention | |
| WO2007048324A1 (fr) | Peptides bioactifs derives de proteine 2 morphogenetiques d’os et leurs procedes de preparation et utilisations | |
| WO2005007098A2 (en) | Nucleic acid therapy to enhance cartilage repair | |
| US20030235564A1 (en) | Compositions and devices comprising or encoding the Run x2 protein and method of use | |
| Schenk et al. | Morphology and chemical composition of connective tissue: bone | |
| WO2002100324A2 (en) | Compositions and methods for the repair and construction of bone and other tissue | |
| KR20050099540A (ko) | Ｎｅｌｌ 펩티드 발현 시스템 및 ｎｅｌｌ 펩티드의 골형성 활성 | |
| Davis et al. | Methods and compositions for bone formation |